Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination
- PMID: 39697445
- PMCID: PMC11652356
- DOI: 10.3389/fneur.2024.1474884
Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination
Abstract
Background: Advances in video image analysis and artificial intelligence provide opportunities to transform how patients are evaluated. In this study, we assessed the ability to quantify Zoom video recordings of a standardized neurological examination- the Myasthenia Gravis Core Examination (MG-CE)-designed for telemedicine evaluations.
Methods: We used Zoom (Zoom Video Communications) videos of patients with myasthenia gravis (MG) who underwent the MG-CE. Computer vision, in combination with artificial intelligence methods, was used to develop algorithms to analyze the videos, with a focus on eye and body motions. To assess the examinations involving vocalization, signal processing methods, such as natural language processing (NLP), were developed. A series of algorithms were developed to automatically compute the metrics of the MG-CE.
Results: A total of 51 patients with MG were assessed, with videos recorded twice on separate days, while 15 control subjects were evaluated once. We successfully quantified the positions of the lids, eyes, and arms and developed respiratory metrics based on breath counts. The cheek puff exercise was found to have limited value for quantification. Technical limitations included variations in illumination, bandwidth, and the fact that the recording was conducted from the examiner's side rather than the patient's side.
Conclusion: Several aspects of the MG-CE can be quantified to produce continuous measurements using standard Zoom video recordings. Further development of the technology will enable trained non-physician healthcare providers to conduct precise examinations of patients with MG outside of conventional clinical settings, including for the purpose of clinical trials.
Keywords: clinical trial; computer vision; deep learning; diplopia; myasthenia gravis; neurological disease; ptosis; telehealth.
Copyright © 2024 Garbey, Lesport, Girma, Öztosun, Abu-Rub, Guidon, Juel, Nowak, Soliven, Aban and Kaminski.
Conflict of interest statement
MG is CEO of Care Constitution Corp. and has patents pending related to present technology. HK is a consultant for Roche, Takeda, Cabaletta Bio, UCB Pharmaceuticals, Canopy Immunotherapeutics, EMD Serono, Ono Pharmaceuticals, ECoR1, Gilde Healthcare, and Admirix, Inc. Argenix provides an unrestricted educational grant to George Washington University. He is an unpaid consultant for Care Constitution. HK has equity interest in Mimivax, LLC. He is supported by NIH U54 NS115054. QL was employed by Care Constitution Corp. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Update of
-
Application of Digital Tools and Artificial Intelligence to the Myasthenia Gravis Core Examination.medRxiv [Preprint]. 2024 Jul 19:2024.07.19.24310691. doi: 10.1101/2024.07.19.24310691. medRxiv. 2024. Update in: Front Neurol. 2024 Dec 04;15:1474884. doi: 10.3389/fneur.2024.1474884. PMID: 39072011 Free PMC article. Updated. Preprint.
References
LinkOut - more resources
Full Text Sources
